Breast Cancer
Conditions
Interventions
placebos group:placebos
Sponsors
The Third Xiangya Hosipital, Central South University
Eligibility
Sex/Gender
Female
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Newly diagnosed breast cancer patients undergoing chemotherapy with liposome-containing doxorubicin regimen; 2. Aged 20 to 60 years; 3. No disease of immune system; 4. Agree to participate in this study and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Suffer from skin diseases such as intractable oral ulcer, psoriasis, eczema, tinea manus and pedis, and other diseases (such as syphilis) that may cause skin damage; 2. Patients with diabetes, impaired glucose tolerance and lactose intolerance; 3. Patients with coronary heart disease, myocardial infarction and poor cardiac function; 4. Patients with extreme organ failure and severe immunosuppression; 5. Participating in other clinical trials; 6. Patients with serious liver and kidney diseases; 7. Have dementia (defined as MMSE score = 2 points) or Parkinson's disease or other neurological diseases causing dysfunction, as well as the history of brain injury, cerebral hemorrhage, stroke, brain tumor, cerebral infarction and other diseases; 8. Advanced patients or patients with other malignant tumors; 9. Having mental illness or family history of mental illness; 10. Alcoholic or drug addicts; 11. Those who refuse to join the group and cannot cooperate with the treatment; 12. In the opinion of the attending physician or researcher, there are other circumstances that are not suitable for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Toxicity of oral, hand, foot and skin mucosa; | — |
Countries
China
Contacts
Public ContactTong Jianbin
The Third Xiangya Hosipital, Central South University
Outcome results
None listed